Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133418) titled 'Clinical research on molecular probes targeting chemokine receptor 4 (CXCR4)' on Sept. 26.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
Condition:
malignant tumor
Intervention:
18F-CXCR4 group:1?F?CXCR4, 3-8 mCi, intravenous injection.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-08
Target Sample Size: 18F-CXCR4 group:10;68Ga-CXCR4 group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345020
Disclaimer: Curated by HT Syndi...